Cargando…
Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK
Fascaplysin, a natural product isolated from marine sponges, is a potential candidate for the development of anti-cancer drugs. However, the mechanism underlying its therapeutic effect of strengthening anti-cancer efficacy of other drugs is poorly understood. Here, we found that fascaplysin increase...
Autores principales: | Oh, Taek-In, Lee, Jun Ho, Kim, Seongman, Nam, Taek-Jin, Kim, Young-Seon, Kim, Byeong Mo, Yim, Woo Jong, Lim, Ji-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943942/ https://www.ncbi.nlm.nih.gov/pubmed/29295560 http://dx.doi.org/10.3390/molecules23010042 |
Ejemplares similares
-
Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA
por: Oh, Taek-In, et al.
Publicado: (2017) -
Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism
por: Kim, Young-Seon, et al.
Publicado: (2018) -
The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity
por: Ampofo, Emmanuel, et al.
Publicado: (2015) -
FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling
por: Shafiq, Muhammad Imtiaz, et al.
Publicado: (2012) -
Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines
por: Hamilton, Gerhard
Publicado: (2014)